Norepinephrine: dissociation of  -receptor binding from adenylate cyclase activation in solubilized myocardium.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D002415:Cats; D002462:Cell Membrane / Q000201:enzymology; D002848:Chromatography, DEAE-Cellulose; D002850:Chromatography, Gel; D066298:In Vitro Techniques; D009206:Myocardium / Q000201:enzymology* / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D010716:Phosphatidylinositols / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D011941:Receptors, Adrenergic; D013501:Surface-Active Agents; D014316:Tritium
D000319:Adrenergic beta-Antagonists; D010716:Phosphatidylinositols; D011941:Receptors, Adrenergic; D013501:Surface-Active Agents; D014316:Tritium; D011433:Propranolol; D000262:Adenylyl Cyclases; D009638:Norepinephrine